VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders
Clinical trial NCT00304005 · COMPLETED
Trial details
- NCT number
- NCT00304005
- Sponsor
- Vion Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2005-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.